156 related articles for article (PubMed ID: 18059486)
1. Nonmonoclonal PTCH gene mutations in psoralen plus UVA-associated basal cell carcinomas.
Heitzer E; Wolf P
J Invest Dermatol; 2008 Mar; 128(3):746-9. PubMed ID: 18059486
[No Abstract] [Full Text] [Related]
2. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
Seidl H; Kreimer-Erlacher H; Bäck B; Soyer HP; Höfler G; Kerl H; Wolf P
J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
[TBL] [Abstract][Full Text] [Related]
3. UV-specific mutations of the human patched gene in basal cell carcinomas from normal individuals and xeroderma pigmentosum patients.
Daya-Grosjean L; Sarasin A
Mutat Res; 2000 May; 450(1-2):193-9. PubMed ID: 10838143
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
Katz KA; Marcil I; Stern RS
J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
[TBL] [Abstract][Full Text] [Related]
5. Basal cell carcinoma: genetic homogeneity in a tumour type displaying phenotypic diversity.
Hoban PR; Lear JT; Strange RC
Eur J Hum Genet; 2006 Sep; 14(9):977-8. PubMed ID: 16723997
[No Abstract] [Full Text] [Related]
6. Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice.
Caty V; Liu Y; Viau G; Bissonnette R
Br J Dermatol; 2006 Apr; 154(4):740-2. PubMed ID: 16536820
[TBL] [Abstract][Full Text] [Related]
7. Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms.
Lacour JP
Br J Dermatol; 2002 Apr; 146 Suppl 61():17-9. PubMed ID: 11966727
[TBL] [Abstract][Full Text] [Related]
8. UV fingerprints predominate in the PTCH mutation spectra of basal cell carcinomas independent of clinical phenotype.
Heitzer E; Lassacher A; Quehenberger F; Kerl H; Wolf P
J Invest Dermatol; 2007 Dec; 127(12):2872-81. PubMed ID: 17597822
[TBL] [Abstract][Full Text] [Related]
9. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
Lim JL; Stern RS
J Invest Dermatol; 2005 Mar; 124(3):505-13. PubMed ID: 15737190
[TBL] [Abstract][Full Text] [Related]
10. PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study.
Soufir N; Gerard B; Portela M; Brice A; Liboutet M; Saiag P; Descamps V; Kerob D; Wolkenstein P; Gorin I; Lebbe C; Dupin N; Crickx B; Basset-Seguin N; Grandchamp B
Br J Cancer; 2006 Aug; 95(4):548-53. PubMed ID: 16909134
[TBL] [Abstract][Full Text] [Related]
11. Skin cancers and their etiologies.
Marghoob AA
Semin Cutan Med Surg; 2011 Dec; 30(4 Suppl):S1-5. PubMed ID: 22177100
[TBL] [Abstract][Full Text] [Related]
12. A non-coding mutation in the 5' untranslated region of patched homologue 1 predisposes to basal cell carcinoma.
Tietze JK; Pfob M; Eggert M; von Preußen A; Mehraein Y; Ruzicka T; Herzinger T
Exp Dermatol; 2013 Dec; 22(12):834-5. PubMed ID: 24131384
[TBL] [Abstract][Full Text] [Related]
13. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.
Reifenberger J; Wolter M; Weber RG; Megahed M; Ruzicka T; Lichter P; Reifenberger G
Cancer Res; 1998 May; 58(9):1798-803. PubMed ID: 9581815
[TBL] [Abstract][Full Text] [Related]
14. PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients.
Harwood CA; Attard NR; O'Donovan P; Chambers P; Perrett CM; Proby CM; McGregor JM; Karran P
Br J Cancer; 2008 Oct; 99(8):1276-84. PubMed ID: 18854826
[TBL] [Abstract][Full Text] [Related]
15. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
Stern RS; Liebman EJ; Väkevä L
J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
[TBL] [Abstract][Full Text] [Related]
16. The spectrum of patched mutations in a collection of Australian basal cell carcinomas.
Evans T; Boonchai W; Shanley S; Smyth I; Gillies S; Georgas K; Wainwright B; Chenevix-Trench G; Wicking C
Hum Mutat; 2000; 16(1):43-8. PubMed ID: 10874304
[TBL] [Abstract][Full Text] [Related]
17. Allelic loss at Drosophila patched gene is highly prevalent in Basal and squamous cell carcinomas of the skin.
Danaee H; Karagas MR; Kelsey KT; Perry AE; Nelson HH
J Invest Dermatol; 2006 May; 126(5):1152-8. PubMed ID: 16484983
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
Reifenberger J; Wolter M; Knobbe CB; Köhler B; Schönicke A; Scharwächter C; Kumar K; Blaschke B; Ruzicka T; Reifenberger G
Br J Dermatol; 2005 Jan; 152(1):43-51. PubMed ID: 15656799
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias.
Kim MY; Park HJ; Baek SC; Byun DG; Houh D
J Dermatol Sci; 2002 May; 29(1):1-9. PubMed ID: 12007715
[TBL] [Abstract][Full Text] [Related]
20. Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients.
Couvé-Privat S; Bouadjar B; Avril MF; Sarasin A; Daya-Grosjean L
Cancer Res; 2002 Dec; 62(24):7186-9. PubMed ID: 12499255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
